BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8131714)

  • 1. Effects of warfarin on thrombosis of the jugular veins of rabbits induced by prolonged stasis.
    Foschi D; Scagnol I; Radaelli E; Pace M; Trabucchi E
    Drugs Exp Clin Res; 1993; 19(4):183-8. PubMed ID: 8131714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
    Kaiser B; Fareed J
    Thromb Haemost; 1996 Oct; 76(4):615-20. PubMed ID: 8903005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antithrombotic effects of warfarin and heparin following infusions of tissue thromboplastin in rabbits: clinical implications.
    Gitel SN; Wessler S
    J Lab Clin Med; 1979 Sep; 94(3):481-8. PubMed ID: 469382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The venous antithrombotic profile of naroparcil in the rabbit.
    Millet J; Theveniaux J; Brown NL
    Thromb Haemost; 1994 Dec; 72(6):874-9. PubMed ID: 7740457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic efficacy of thrombin inhibitor L-374,087: intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis.
    Cook JJ; Gardell SJ; Holahan MA; Sitko GR; Stump GL; Wallace AA; Gilberto DB; Hare TR; Krueger JA; Dyer DL; Sanderson PE; Vacca JP; Shafer JA; Lynch JJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):503-10. PubMed ID: 10087043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of factor XI reduces thrombus formation in rabbit jugular vein under endothelial denudation and/or blood stasis.
    Takahashi M; Yamashita A; Moriguchi-Goto S; Sugita C; Matsumoto T; Matsuda S; Sato Y; Kitazawa T; Hattori K; Shima M; Asada Y
    Thromb Res; 2010 May; 125(5):464-70. PubMed ID: 20089298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939)--an oral, direct factor Xa inhibitor.
    Biemond BJ; Perzborn E; Friederich PW; Levi M; Buetehorn U; Büller HR
    Thromb Haemost; 2007 Mar; 97(3):471-7. PubMed ID: 17334516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of ethanol extract from Radix Ophiopogon japonicus on venous thrombosis linked with its endothelium-protective and anti-adhesive activities.
    Kou J; Yu B; Xu Q
    Vascul Pharmacol; 2005 Sep; 43(3):157-63. PubMed ID: 16054441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patency of venous grafts in small veins: influence of aspirin and warfarin sodium.
    Friedman EW; Frank HA; Ponn R
    Arch Surg; 1977 Sep; 112(9):1072-3. PubMed ID: 901174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action and monitoring of anticoagulants.
    Hirsh J
    Semin Thromb Hemost; 1986 Jan; 12(1):1-11. PubMed ID: 3961504
    [No Abstract]   [Full Text] [Related]  

  • 11. Overuse of prothrombin and partial thromboplastin coagulation tests in medical inpatients.
    Pilsczek FH; Rifkin WD; Walerstein S
    Heart Lung; 2005; 34(6):402-5. PubMed ID: 16324959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study of human annexin V derivative: its effects of anticoagulation and antithrombosis].
    Ju CW; Wang LS; Yang X; Ma GS; Hua ZC; Gao XY
    Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):540-3. PubMed ID: 15569533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some effects of purified autoprothrombin C in blood clotting.
    Müller-Berghaus G; Seegers WH
    Thromb Diath Haemorrh; 1966 Dec; 16(3):707-22. PubMed ID: 5996683
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-thrombotic effect of chronic oral treatment with Orbignya phalerata Mart.
    Azevedo AP; Farias JC; Costa GC; Ferreira SC; Aragão-Filho WC; Sousa PR; Pinheiro MT; Maciel MC; Silva LA; Lopes AS; Barroqueiro ES; Borges MO; Guerra RN; Nascimento FR
    J Ethnopharmacol; 2007 Apr; 111(1):155-9. PubMed ID: 17141996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of heparin, low molecular weight (LMW) heparin, and a heparin analogue on experimental venous thrombosis in the rabbit.
    Björck CG; Bergqvist D; Esquivel C; Nilsson B; Rudsvik Y
    Acta Chir Scand; 1984; 150(8):629-33. PubMed ID: 6085202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin prevents stasis-induced thrombosis through protection of the venous endothelial cells: an electron microscopic study in rabbits.
    Trabucchi E; Foschi D; Marazzi M; Abelli P; Andriuoli G; Lami F; Scagnol I; Del Soldato P; De Santis F; Montorsi W
    Haemostasis; 1991; 21(1):37-44. PubMed ID: 1864555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of warfarin in arterial thrombosis: evidence from a vascular prosthesis model in rats.
    Reyers I; de Gaetano G; Donati MB
    Thromb Haemost; 1983 Dec; 50(4):821-3. PubMed ID: 6665763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin therapy. 2.
    Deykin D
    N Engl J Med; 1970 Oct; 283(15):801-3. PubMed ID: 4917271
    [No Abstract]   [Full Text] [Related]  

  • 19. Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in rats.
    Schumacher WA; Seiler SE; Steinbacher TE; Stewart AB; Bostwick JS; Hartl KS; Liu EC; Ogletree ML
    Eur J Pharmacol; 2007 Sep; 570(1-3):167-74. PubMed ID: 17597608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental arterial thrombosis in genetically or diet induced hyperlipidemia in rats--role of vitamin K-dependent clotting factors and prevention by low-intensity oral anticoagulation.
    De Curtis A; D'Adamo MC; Amore C; Polishchuck R; Castelnuovo AD; Donati MB; Iacoviello L
    Thromb Haemost; 2001 Dec; 86(6):1440-8. PubMed ID: 11776312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.